Skip to main content
Kubota Pharmaceutical Holdings Co., Ltd. logo

Kubota Pharmaceutical Holdings Co., Ltd. — Investor Relations & Filings

Ticker · 4596 ISIN · JP3266500002 T Manufacturing
Open in API
Filings indexed 70 across all filing types
Latest filing 2026-05-22 Share Issue/Capital Cha…
Country JP Japan
Listing T 4596

About Kubota Pharmaceutical Holdings Co., Ltd.

https://www.kubotaholdings.co.jp/en/

Kubota Pharmaceutical Holdings Co., Ltd., through its subsidiary Kubota Vision Inc., is a clinical-stage company dedicated to developing novel treatments for ophthalmic diseases. Its mission is to translate scientific innovation into a diverse portfolio of drugs and devices to preserve and restore vision for people worldwide. The company's development pipeline features emixustat hydrochloride, a therapeutic candidate for Stargardt disease. In the device segment, Kubota is commercializing Kubota Glass®, a wearable technology designed to manage myopia. The company focuses on creating solutions to address the root causes of blindness and vision impairment.

Recent filings

Filing Released Lang Actions
訂正臨時報告書
Share Issue/Capital Change Classification · 90% confidence The document is a corrected “臨時報告書” (extraordinary report) filed to the Kanto Finance Bureau under Japan’s Financial Instruments and Exchange Act. It details the issuance of 1,740,000 new shares (restricted stock compensation) to a director, specifying issuance price, capital incorporation amounts, and conditions of share restrictions. This is a corporate action announcement regarding new share issuance, fitting the “Share Issue/Capital Change” category. Therefore, it should be classified as SHA.
2026-05-22 Japanese
臨時報告書
Share Issue/Capital Change Classification · 90% confidence The document is a Japanese ‘臨時報告書’ (timely disclosure/extraordinary report) filed under the Financial Instruments and Exchange Act, detailing the issuance of new restricted shares to directors (number of shares, issue price, allocation, terms of transfer restrictions). It is an announcement of a new share issue/capital change rather than a periodic report or an earnings/annual report. This fits the Share Issue/Capital Change category.
2026-04-27 Japanese
臨時報告書
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a Japanese ‘臨時報告書’ filed under the Financial Instruments and Exchange Act, detailing the date of the shareholders’ meeting, description of each resolution and the vote counts (for, against, abstain) along with approval percentages. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements (DVA)” since it reports official vote results for general meeting proposals.
2026-04-27 Japanese
譲渡制限付株式報酬としての新株式の発行に関するお知らせ
Regulatory Filings
2026-04-24 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a report, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2025
2026-03-27 Japanese
有価証券報告書－第11期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese Annual Securities Report required under the Financial Instruments and Exchange Act. It contains comprehensive financial statements, business descriptions, and management information for the fiscal year ending December 31, 2025. This corresponds to the 10-K filing category. FY 2025
2026-03-27 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.